DK0443224T3 - Anvendelse af thrombospondin til fremskyndelse af sårheling - Google Patents
Anvendelse af thrombospondin til fremskyndelse af sårhelingInfo
- Publication number
- DK0443224T3 DK0443224T3 DK90250335.8T DK90250335T DK0443224T3 DK 0443224 T3 DK0443224 T3 DK 0443224T3 DK 90250335 T DK90250335 T DK 90250335T DK 0443224 T3 DK0443224 T3 DK 0443224T3
- Authority
- DK
- Denmark
- Prior art keywords
- thrombospondin
- wound healing
- accelerate wound
- pharmaceutical compositions
- accelerate
- Prior art date
Links
- 102000002938 Thrombospondin Human genes 0.000 title abstract 2
- 108060008245 Thrombospondin Proteins 0.000 title abstract 2
- 230000029663 wound healing Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/483,500 US5155038A (en) | 1990-02-22 | 1990-02-22 | Use of thrombospondin to promote wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0443224T3 true DK0443224T3 (da) | 1994-05-02 |
Family
ID=23920296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90250335.8T DK0443224T3 (da) | 1990-02-22 | 1990-12-21 | Anvendelse af thrombospondin til fremskyndelse af sårheling |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5155038A (da) |
| EP (1) | EP0443224B1 (da) |
| JP (1) | JPH04211019A (da) |
| AT (1) | ATE103815T1 (da) |
| CA (1) | CA2031817C (da) |
| DE (1) | DE69007964T2 (da) |
| DK (1) | DK0443224T3 (da) |
| ES (1) | ES2063250T3 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5192744A (en) * | 1990-01-12 | 1993-03-09 | Northwestern University | Method of inhibiting angiogenesis of tumors |
| US5468505A (en) * | 1992-02-28 | 1995-11-21 | Board Of Regents, The University Of Texas System | Local delivery of fibrinolysis enhancing agents |
| US5399667A (en) * | 1993-03-05 | 1995-03-21 | Washington University | Thrombospondin receptor binding peptides |
| US5627265A (en) * | 1993-03-05 | 1997-05-06 | Washington University | Receptor for cell-binding domain of thrombospondins |
| US6528483B2 (en) | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
| US5641483A (en) * | 1995-06-07 | 1997-06-24 | Beaulieu; Andre | Wound healing formulations containing human plasma fibronectin |
| US5877149A (en) | 1995-06-07 | 1999-03-02 | Beaulieu; Andre | Deepithelialized skin diffusion cell system |
| US7112320B1 (en) | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
| US5733884A (en) | 1995-11-07 | 1998-03-31 | Nestec Ltd. | Enteral formulation designed for optimized wound healing |
| CN1069213C (zh) * | 1995-12-08 | 2001-08-08 | 上海贝特生物技术有限公司 | 造血前体细胞保护剂 |
| US6461640B1 (en) | 1995-12-08 | 2002-10-08 | Board Of Regents, The University Of Texas System | Local delivery of fibrinolysis enhancing agents |
| US7067117B1 (en) | 1997-09-11 | 2006-06-27 | Cambridge University Technical Services, Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
| US6989435B2 (en) | 1997-09-11 | 2006-01-24 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
| US6716963B1 (en) * | 1998-05-22 | 2004-04-06 | Abbott Laboratories | Peptide antiangiogenic drugs |
| MXPA00000009A (es) | 1998-06-22 | 2005-09-08 | Autologous Wound Therapy Inc | Solicitud para patente de utilidad para curativo de heridas mejorado enriquecido con plaquetas. |
| US7238711B1 (en) | 1999-03-17 | 2007-07-03 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
| US6380161B1 (en) | 1999-06-21 | 2002-04-30 | Inkine Pharmaceutical Company, Inc. | Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions |
| US20020049312A1 (en) * | 2000-05-23 | 2002-04-25 | Turner C. Alexander | Noel human thrombospondin-like proteins and polynucleotides encoding the same |
| EP3813861A4 (en) * | 2018-06-27 | 2022-08-10 | Juvena Therapeutics, Inc. | HEPARIN-ASSOCIATED POLYPEPTIDES AND THEIR USES |
| CN115379850A (zh) | 2019-12-24 | 2022-11-22 | 裘美娜治疗公司 | 再生性多肽及其用途 |
| CN117999278A (zh) | 2021-06-21 | 2024-05-07 | 裘美娜治疗公司 | 再生性多肽及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4614517A (en) * | 1982-08-04 | 1986-09-30 | La Jolla Cancer Research Foundation | Tetrapeptide |
| US4792525A (en) * | 1982-08-04 | 1988-12-20 | La Jolla Cancer Research Foundation | Tetrapeptide |
| US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
-
1990
- 1990-02-22 US US07/483,500 patent/US5155038A/en not_active Expired - Fee Related
- 1990-12-07 CA CA002031817A patent/CA2031817C/en not_active Expired - Fee Related
- 1990-12-21 ES ES90250335T patent/ES2063250T3/es not_active Expired - Lifetime
- 1990-12-21 DE DE69007964T patent/DE69007964T2/de not_active Expired - Fee Related
- 1990-12-21 AT AT90250335T patent/ATE103815T1/de not_active IP Right Cessation
- 1990-12-21 DK DK90250335.8T patent/DK0443224T3/da active
- 1990-12-21 EP EP90250335A patent/EP0443224B1/en not_active Expired - Lifetime
-
1991
- 1991-02-19 JP JP3045368A patent/JPH04211019A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0443224A1 (en) | 1991-08-28 |
| ES2063250T3 (es) | 1995-01-01 |
| DE69007964D1 (de) | 1994-05-11 |
| US5155038A (en) | 1992-10-13 |
| DE69007964T2 (de) | 1994-09-22 |
| EP0443224B1 (en) | 1994-04-06 |
| CA2031817A1 (en) | 1991-08-23 |
| ATE103815T1 (de) | 1994-04-15 |
| JPH04211019A (ja) | 1992-08-03 |
| CA2031817C (en) | 2002-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0443224T3 (da) | Anvendelse af thrombospondin til fremskyndelse af sårheling | |
| MX9304710A (es) | Composicion farmaceutica y/o cosmetica y su uso. | |
| FI892454A0 (fi) | Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma. | |
| BR9403783A (pt) | Uso de uma composição cosmética | |
| MX9102353A (es) | N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen. | |
| NL300136I2 (nl) | Farmacologisch actieve catecholderivaten en samenstellingen ervan. | |
| EP0202298A4 (en) | MEDICINE FOR Wounds. | |
| SE7903186L (sv) | Cerebralverksamt medel | |
| ES2101230T3 (es) | Nuevos derivados de sustancias anti-inflamatorias, analgesicas y/o antipireticas no estereoideas, su uso y formulaciones farmaceuticas que las contienen. | |
| ES2068935T3 (es) | Piridazinonas con actividad insecticida y acaricida y composiciones que las contienen. | |
| DE68913739D1 (de) | Kosmetische und hautbehandlungs-zusammensetzungen. | |
| SE8404065D0 (sv) | Novel biologically active compounds | |
| ES2134237T3 (es) | Composiciones farmaceuticas que contienen acido ursodesoxicolico. | |
| IT1240683B (it) | Composizione farmaceutica contenente egf | |
| ATE126435T1 (de) | Antiherpes-castanosperminester. | |
| SE8600658D0 (sv) | Novel composition of matter | |
| ATE158947T1 (de) | Hautregenerierende kosmetische zusammensetzung | |
| IT8021550A0 (it) | Derivati adenosinici ad attivita'antinfiammatoria ed analgesica e composizioni terapeutiche che licontengono come principio attivo. | |
| IT8024604A0 (it) | Formulazioni biodegradabili che favoriscono la crescita eprocedimento di trattamento. | |
| DE69104961D1 (de) | Anwendung von Thiazolylalkoxyacrylaten in der Herstellung von Insektiziden und/oder Akanizide-Zusammensetzungen. | |
| ITTO930024A0 (it) | Composizione per accelerare la rimarginazione di ferite | |
| ITMI912466A1 (it) | Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche | |
| ATE189395T1 (de) | Verwendung von protease nexin-i als mittel gegen entzündungen | |
| DE68905076D1 (de) | Pharmazeutische zusammensetzung fuer die behandlung von hautwunden. | |
| ATE132877T1 (de) | Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung |